Results 141 to 150 of about 34,537 (182)

Tenofovir-Associated Hypophosphatemic Osteomalacia in an HIV-Infected Patient: A Case Report. [PDF]

Cureus
Iyiyapici Unubol A, Unubol M.
europepmc   +1 more source

Individualized immunotherapy for immune reconstitution-associated cortical encephalitis in an HIV-positive cryptococcal meningitis patient: a case report. [PDF]

Front Immunol
Wang W, Tang S, Yang J, Wen Y.
europepmc   +1 more source

Bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir plus lamivudine plus tenofovir disoproxil fumarate in people living with HIV experiencing virologic failure in China: a study protocol for a multicenter, open-label, randomized controlled non-inferiority trial. [PDF]

Trials
Wang R, Ren Y, Li R, Liu H, Liu X, Hua W, Wang X, Cao Y, Sun L, Dai L.   +9 more
europepmc   +1 more source

Treatment-Emergent Bictegravir Resistance in a Treatment-Naive Individual With HIV Infection: A Case Report. [PDF]

Cureus
Dubson I, Gaur A, Jose J, Andrews C, Gaballa A, McFarlane SI.   +5 more
europepmc   +1 more source

To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? [PDF]

Curr HIV/AIDS Rep
Debroy P, Lake JE.
europepmc   +1 more source

Immune recovery following switch from EFV-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed immunological non-responders: a 144-week real-world cohort study in China. [PDF]

Front Immunol
Yang H, Yu Q, Li M, Liu M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tenofovir

Reactions Weekly, 2018
  +9 more sources